Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (ANCHOR)


January 1, 2009

Clinical Trial

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T.

Ophthalmology. 2009 Jan;116(1):57-65.e5.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive